Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings

INTRODUCTION: Despite the rising burden of chronic respiratory disease globally, and although many respiratory medications are included in the World Health Organization Essential Medications List (WHO-EML), there is limited information concerning the availability and affordability of treatment drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddharthan, Trishul, Robertson, Nicole M., Rykiel, Natalie A., Underhill, Lindsay J., Rahman, Nihaal, Kafle, Sujan, Mohan, Sakshi, Padalkar, Roma, McKeown, Sarah, Flores-Flores, Oscar, Quaderi, Shumonta A., Alupo, Patricia, Kalyesubula, Robert, Kirenga, Bruce, Luo, Jing, Cárdenas, Maria Kathia, Gianella, Gonzalo, Miranda, J. Jaime, Checkley, William, Hurst, John R., Pollard, Suzanne L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021856/
https://www.ncbi.nlm.nih.gov/pubmed/36962898
http://dx.doi.org/10.1371/journal.pgph.0001309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021856/
https://www.ncbi.nlm.nih.gov/pubmed/36962898
http://dx.doi.org/10.1371/journal.pgph.0001309

Ejemplares similares